Daily Health Headlines

Stem cells could cure hereditary deafness within 5 years

👤by FoxNews.com 0 comments 🕔Monday, November 21st, 2016

Scientists believe they are on the brink of a cure for people born deaf after producing stem cells to correct a hereditary defect.

Experts have found a way of growing new cells for the cochlea, the spiral cavity of the inner ear.

These can be used to replace faulty ones in people deaf from birth due to a genetic error.

They hope a treatment could be available to patients within five to 10 years.

Scientists find method for restoring hearing loss in mice Hearing loss: Could your headphones be to blame? Revolutionary treatments for hearing loss

Professor Kazusaku Kamiya, a specialist in ear diseases who is leading the research, said: "I am very excited by what we have done. We hope this work will lead to a cure for a form of hereditary deafness.

"We have found a way to make cochlear stem cells. The next step is to find a way to safely inject them into the patient┬┤s ear."

The work, which is being carried out in a laboratory at Juntendo University in Tokyo, Japan, aims to correct a mutation in a gene called Gap Junction Beta 2, which accounts for deafness or hearing loss for one in a thousand children.

Click for more from the Sun.

Article Credits / Source

FoxNews.com

FoxNews.com provides up to the minute breaking health news. Click here to view this full article from FoxNews.com.

View More Articles From FoxNews.com 🌎View Article Website

Sponsored Product

Lunar Sleep for $1.95

Lunar Sleep for $1.95

People who have trouble sleeping typically have low levels of melatonin, so melatonin supplements seem like a logical fix for insomnia. There is a high demand for sleep aids, especially in the U.S. The National Health Interview Survey done in 2002, and again in 2007, found 1.6 million US adults were using complementary and alternative sleep aids for insomnia. Lunar Sleep was a top choice. Use Promo Code: Sleep2014 and only pay $1.95 S&H.

Get Lunar Sleep for $1.95

More Health Headlines Articles

Johnson & Johnson in early talks to buy drugmaker Actelion

Johnson & Johnson in early talks to buy drugmaker Actelion0

NEW YORK -  Johnson & Johnson is in early talks to buy the Swiss drugmaker Actelion Pharmaceuticals. Actelion Pharmaceuticals Ltd. makes high blood pressure medicines that treat arteries in the lung and around the heart. Johnson & ...

IVF calculator may help predict chances of having a baby

IVF calculator may help predict chances of having a baby0

A new calculator can help couples see their odds of success with in vitro fertilization (IVF) before they start treatment, a recent study suggests. Doctors have traditionally been reluctant to estimate couples' chances of having a baby before ...

Chronic gum disease tied to risk of erectile dysfunction

Chronic gum disease tied to risk of erectile dysfunction0

Erectile dysfunction is more common in men with gum disease, according to a new review of existing studies. Chronic bacterial infection of the gums, or periodontitis, is common and a major cause of tooth loss for adults, the authors write. The ...

Are colds and flu worse in women than in men?

Are colds and flu worse in women than in men?0

Colds and the flu may take a bigger toll on women than men, according to a new study based on people's reports of their own symptoms. The women in the study were more likely than the men in the study to report severe fatigue and muscle aches ...

Why fewer Americans say they want to lose weight

Why fewer Americans say they want to lose weight0

Americans today are less likely to say they want to lose weight, compared to those surveyed a decade ago, according to a new poll. The poll, from Gallup, found that an average of 53 percent of American adults who were polled between 2010 and ...

View More Health Headlines Articles

0 Comments

Write a Comment

Your email address will not be published. Required fields are marked *

Our Mailing List

Subscribe to our mailing list to get the latest health news as it breaks!

Your information will not be shared with anyone!